BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. Since its inception, the company has executed eight clinical trials including a seven country, 12,400 participant Phase 3 trial of its vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline. www.biondvax.com.
View Top Employees from BiondVax Pharmaceuticals Ltd.| Website | http://www.biondvax.com |
| Ticker | BVXV |
| Revenue | $779000 |
| Funding | $22.3 million |
| Employees | 36 (23 on RocketReach) |
| Founded | 2003 |
| Address | JERUSALEM BIOPARK, 2ND Fl HADASSAH EIN KEREM CAMPUS, Jerusalem, Jerusalem, IL |
| Phone | +972 8-930-2529 |
| Fax | +972 8-930-2531 |
| Industry | Pharmaceuticals, Biotechnology Research, Drug Manufacturing & Research, Health Care, Universal Flu Vaccine, Information Technology, Other Healthcare Services, Influenza, Healthcare, Flu Vaccine, BiondVax, Vaccines, Biotechnology, Recombinant Proteins |
| Web Rank | 8 Million |
| Keywords | Biondvax, Biondvax Pharma, Biondvax’S M-001, Epitope Analysis For Influenza Vaccine Design, M-001 Biondvax Pharmaceuticals |
| Competitors | FLUGEN INC, Osivax, Precision Biologics, Soligenix, Inc., Vaccitech |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular BiondVax Pharmaceuticals Ltd. employee's phone or email?
BiondVax Pharmaceuticals Ltd. Questions
The BiondVax Pharmaceuticals Ltd. annual revenue was $779000 in 2023.
Ron Babecoff is the Founder, President and Chief Executive Officer of BiondVax Pharmaceuticals Ltd..
23 people are employed at BiondVax Pharmaceuticals Ltd..
BiondVax Pharmaceuticals Ltd. is based in Jerusalem, Jerusalem.
The NAICS codes for BiondVax Pharmaceuticals Ltd. are [3254, 32, 32541, 325].
The SIC codes for BiondVax Pharmaceuticals Ltd. are [28, 283].
Top BiondVax Pharmaceuticals Ltd. Employees
-
ViewAmir Reichman
Chief Executive Officer at BiondVax Pharmaceuticals Ltd.
Jerusalem District, Israel52 -
ViewJoshua Phillipson
Director Of Business Development and Investor Relations at BiondVax Pharmaceuticals Ltd.
Jerusalem, Yerushalayim, Israel3 -
ViewZohar Gadri
Production Process Development and Business Development at BiondVax Pharmaceuticals Ltd.
Rehovot, Center District, Israel21 -
View
George Lowell
Member Board Of Directors at BiondVax Pharmaceuticals Ltd.
Center District, Israel15+ -
View
Oded Ovadia
Director,analytics and preclinical trials at BiondVax Pharmaceuticals Ltd.
Jerusalem, Yerushalayim, Israel2
Related Companies
